Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 24, 2023

Heritage Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for HERITAGE PHARMS, and what generic and branded alternatives to HERITAGE PHARMS drugs are available?

HERITAGE PHARMS has thirty-eight approved drugs.

Summary for Heritage Pharms

US Patents:	0
Tradenames:	34
Ingredients:	33
NDAs:	38

Drugs and US Patents for Heritage Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Heritage Pharms	GLIPIZIDE AND METFORMIN HYDROCHLORIDE	glipizide; metformin hydrochloride	TABLET;ORAL	078728-003	Jun 23, 2010	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Heritage Pharms	VERAPAMIL HYDROCHLORIDE	verapamil hydrochloride	TABLET;ORAL	071881-002	Oct 14, 2015	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Heritage Pharms Inc	METRONIDAZOLE	metronidazole	TABLET;ORAL	205245-002	Sep 23, 2015	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
Heritage Pharms	NYSTATIN	nystatin	TABLET;ORAL	062474-001	Dec 22, 1983	AA	RX	No	No		See Plans and Pricing				See Plans and Pricing
Heritage Pharms Inc	DOLENE	propoxyphene hydrochloride	CAPSULE;ORAL	080530-001	Approved Prior to Jan 1, 1982		DISCN	No	No		See Plans and Pricing				See Plans and Pricing
Heritage Pharms	VERAPAMIL HYDROCHLORIDE	verapamil hydrochloride	TABLET;ORAL	071881-001	Apr 5, 1988	AB	RX	No	Yes		See Plans and Pricing				See Plans and Pricing
Heritage Pharms	NIMODIPINE	nimodipine	CAPSULE;ORAL	077811-001	May 2, 2007	AB	RX	No	No		See Plans and Pricing				See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Heritage Pharms

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Heritage Pharms Inc	LIMBITROL	amitriptyline hydrochloride; chlordiazepoxide	TABLET;ORAL	016949-001	Approved Prior to Jan 1, 1982	4,316,897	See Plans and Pricing
Heritage Pharms Inc	LIMBITROL DS	amitriptyline hydrochloride; chlordiazepoxide	TABLET;ORAL	016949-002	Approved Prior to Jan 1, 1982	4,316,897	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Harvard Business School

Merck

Boehringer Ingelheim

Mallinckrodt

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.